Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease: Results at 1 Year

Archives of Neurology

Volumn 47, Issue 5, 1990, Pages 505-512

  Freed, Curt R ^a   Breeze, Robert E ^a   Rosenberg, Neil L ^a   Schneck, Stuart A ^a   Wells, Trent H ^a   Barrett, John N ^b   Grafton, Scott T ^b   Huang, S C ^c   Eidelberg, David ^c   Rottenberg, David A ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b Trent Wells Inc ^*  (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA; RADIOISOTOPE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CASE REPORT; DOPAMINERGIC NERVE CELL; DRUG COMBINATION; DRUG THERAPY; HUMAN; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSPLANTATION;

BRAIN; CASE REPORT; DOPAMINE; FETUS; FOLLOW-UP STUDIES; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGE; MOVEMENT; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0025261943     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1990.00530050021007     Document Type: Article

References (42)

1. German DC, Schlusselberg DS, Woodward DJ. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J Neural Transm. 1983;57:243-254.
2. Ehringer H, Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr. 1960;38:1236-1239.
3. Bjorklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979;177:555-560.
4. Perlow MJ, Freed WJ, Hoffer BJ, et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 1979;204:643-647.
5. Bakay RAE, Barrow DL, Schiff A, Fiandanca MS. Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation. Appi Neurophysiol. 1985;48:358-361.
6. Redmond DE, Sladek JR, Roth RH, et al. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet. 1986;1:1125-1127.
7. Freed CR, Richards JB, Sabol KE, Reite ML. Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP-induced Parkinsonism. In: Beart PM, Woodruff G, Jackson DM, eds. Pharmacology and Functional Regulation of Dopaminergic Neurons. New York, NY: Macmillan Publishing Co Inc; 1988:353-360.
8. Dunnett SB, Bjorklund A, Schmidt RH, Stenevi U, Iversen SD. Intracerebral grafting of neuronal cell suspensions, IV: behavioral recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand. 1984;522(suppl):29-37.
9. Richards JB, Freed CR. Effects of fetal substantia nigra transplants on lesion-induced deficits in trained circling behavior. Soc Neurosci. 1987;13:831. Abstract.
10. Brundin P, Nilsson OG, Strecker RE, et al. Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Brain Res. 1986;65:235-240.
11. Stromberg I, Bygdeman M, Goldstein M, Seiger A, Olson L. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation. Neurosci Lett. 1986;71:271-276.
12. Madrazo I, Leon V, Torres C, et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med. 1988;318:51.
13. Hitchcock ER, Clough C, Hughes R, Kenny B. Embryos and Parkinson's disease. Lancet. 1988;1:1274.
14. Freed CR, Breeze RE, Rosenberg N, Barrett JN, Rottenberg DA. Transplant of human fetal dopamine cells in a patient with Parkinson's disease. Clin Res. 1989;37:527A. Abstract.
15. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol. 1989;46:615-631.
16. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J, Torres C, Becerril JJ. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med. 1987;316:831-834.
17. Lindvall O, Backlund E-O, Farde L, et al. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol. 1987;22:457-468.
18. Goetz CG, Olanow CW, Koller WC, et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 1989;320:337-341.
19. Allen GS, Burns RS, Tulpan NB, Parker RA. Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease: initial clinical results in 18 patients. Arch Neurol. 1989;46:487-491.
20. Hurtig H, Joyce J, Sladek JR, Trojanowski JQ. Postmortem analysis of adrenal medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol. 1989;25:607-614.
21. Waters CH, Weiner LP, Apuzzo MLJ, et al. Adrenal to caudate transplantation: postmortem examination. Neurology. 1989;39(suppl 1):127.
22. Unsicker K, Krisch B, Otten U, Thoenen H. Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci USA. 1978;75:3498-3502.
23. Stromberg I, Herrera-Marschitz M, Ungerstedt U, Edbendal T, Olson L. Chronic implants of chromaffin tissue into the dopamine-denervated striatum: effects of NGF on graft survival, fiber growth, and rotational behavior. Exp Brain Res. 1985;60:335-349.
24. Notter MFD, Gupta M, Gash DM. Neuronal properties of monkey adrenal medulla in vitro. Cell Tissue Res. 1986;244:69-76.
25. Barrett JN, Kriek EH, Nonner D, et al. Studies of human fetal neural tissue in culture. Soc Neurosci. 1988;14:1004. Abstract.
26. Bohn MC, Cupit L, Marciano F, Gash DM. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 1987;237:913-916.
27. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Kopin IJ, Cummins A, Oldfield EH. Implant induced catecholaminergic sprouting in MPTP parkinsonian monkeys: behavioral and histochemical studies. Soc Neurosci. 1988;14:18. Abstract.
28. Freed WJ, Morihisa JM, Spoor E, et al. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature. 1981;292:351-352.
29. Morihisa JM, Nakamura RK, Freed WJ, Mishkin M, Wyatt RJ. Adrenal medulla grafts survive and exhibit catecholamine specific fluorescence in the primate brain. Exp Neurol. 1984;84:643-653.
30. Fahn S, Elton RL, and Members of the UPDRS Development Committee. Unified Parkinson Disease Rating Scale. In Fahn S, Marsden CD, Goldstein M, et al, eds. Recent Developments in Parkinson's Disease II. New York, NY: Macmillan Publishing Co Inc; 1987:153-163.
31. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic anatomy of Parkinson's disease: complementary 18F-fluorodeoxyglucose and 18F-fluorodopa positron emission tomographic studies. Movement Dis. In press.
32. Luxen A, Barrio JR, Bida GT, Satyarmurthy N. Regioselective radiofluorodemercuration: a simple high yield synthesis of 6-(F-18) fluorodopa. In: Program and abstracts of the Sixth International Symposium in Radiopharmaceutical Chemistry; 1986; Boston, Mass: 16.
33. Prober CG, Hensleigh PA, Boucher FD, et al. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med. 1988;318:887-891.
34. Brundin P, Nilsson OG, Gage FH, Bjorklund A. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res. 1985;60:204-208.
35. Redmond DE Jr, Naftolin F, Collier TJ, et al. Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys. Science. 1988;242:768-771.
36. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med. 1988;318:876-880.
37. Freed CR. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med. 1988;319:370-371.
38. Evarts EV, Teravainen H, Calne DB. Reaction time in Parkinson's disease. Brain. 1981;104:167-186.
39. Bloxham CA, Mindel TA, Frith CD. Initiation and execution of predictable and unpredictable movements in Parkinson's disease. Brain. 1984;107:371-384.
40. Guttman M, Burns RS, Martin WRW, et al. PET studies of parkinsonian patients treated with autologous adrenal implants. Can J Neurol Sci. 1989;16:305-309.
41. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 1990;247:574-577.
42. Steece-Collier K, Collier JJ, Sladek CD, Sladek K, Jr. Chronic L-dopa treatment decreases the viability of grafted and embryonic rat mesencephalic dopamine neurons. Soc Neurosci. 1989;15(1):1354. Abstract 533.6.